Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
120.27
-4.06 (-3.27%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Neurocrine Biosciences Revenue

Neurocrine Biosciences had revenue of $622.10M in the quarter ending September 30, 2024, with 24.72% growth. This brings the company's revenue in the last twelve months to $2.24B, up 25.72% year-over-year. In the year 2023, Neurocrine Biosciences had annual revenue of $1.89B with 26.76% growth.

Revenue (ttm)
$2.24B
Revenue Growth
+25.72%
P/S Ratio
5.36
Revenue / Employee
$1,602,000
Employees
1,400
Market Cap
12.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.89B398.40M26.76%
Dec 31, 20221.49B355.20M31.34%
Dec 31, 20211.13B87.60M8.38%
Dec 31, 20201.05B257.80M32.71%
Dec 31, 2019788.10M336.90M74.67%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG 20.80B
Smith & Nephew 5.64B
Catalent 4.38B
AptarGroup 3.57B
Teleflex 3.01B
Royalty Pharma 2.24B
Medpace Holdings 2.07B
Sarepta Therapeutics 1.50B
Revenue Rankings